After decoding how next-gen antibody formats—biparatopic, tetravalent, bispecific—reshaped the front end of ADC targeting, this Medness feature asks: what happens after you’ve built the “smartest” antibody possible? The answer is chemistry. In this installment, Suhail Ahmed Kabeer Rasheed explores how site-specific conjugation—once a technical afterthought—is now quietly powering the most precise, potent, and reliable ADCs ever made.
Learn how controlling where and how many payloads are linked to each antibody has become a decisive factor in both patient safety and drug efficacy. Why is site-specific conjugation increasingly the industry standard? And how is it enabling innovations like dual payloads, logic-gated release, and true “biology-matched” dosing?
(Click anywhere on the image to expand)




Disclaimer
The editors take care to share authentic information. In case of any discrepancies please write to newsletter@medness.org.
The sponsors do not have any influence on the nature or kind of the news/analysis reported in MedNess. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of MedNess. Examples of analysis performed within this article are only examples. They should not be utilized in real-world analytic products as they are based only on very limited and dated open-source information. Assumptions made within the analysis are not reflective of the position of anyone volunteering or working for MedNess. This blog is strictly for news and information. It does not provide medical advice, diagnosis or treatment nor investment suggestions. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
MedNess is a part of STEMPeers® which is a 501(c)(3) organization registered in PA as PhD Career Support Group. The organization helps create a growing network of STEM scientists that is involved in peer-to-peer mentoring and support.


